Clinical Trials Directory

Trials / Completed

CompletedNCT04414800

Intranasal Ketamine Versus Intranasal Fentanyl

Intranasal Ketamine Versus Intranasal Fentanyl on Pain Management in Isolated Traumatic Patients

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
125 (actual)
Sponsor
Isfahan University of Medical Sciences · Academic / Other
Sex
All
Age
15 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Abstract Background: Given the inadequate control of pain in patients with injury that refer to the emergency departments, the rapid onset of action of intranasal administration in pain management, and the avoidance of administering opioid medications, the present study aimed at evaluating the effect of intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients Materials and Methods: The current study was performed on 125 patients that were divided into the following three groups: control group (n = 41), 1 mg/kg intranasal ketamine group (n = 40), and 1μg/kg intranasal fentanyl group (n = 44). Then pain scores, HR, RR, BP, and SaO2 were recorded at baseline, 5, 10, 15, 30, and 40 minutes after the intervention.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboDistilled water
DRUGKetamine1 mg/kg intranasal ketamine
DRUGFentanyl1μg/kg intranasal fentanyl

Timeline

Start date
2017-04-01
Primary completion
2018-03-20
Completion
2018-04-15
First posted
2020-06-04
Last updated
2020-06-04

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT04414800. Inclusion in this directory is not an endorsement.